Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2

Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2

US Patent 11033540 · Granted Jun 15, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Nuclear reactor flow control devices and associated reactors, components, and me2024
Methods of manufacturing benzoquinoline compounds2024
Halogen-substituted phenylate compound and applications thereof2024
Analogs of deutetrabenazine, their preparation and use2023
Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of ves2023
Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of ves2023
Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of ves2023
Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of ves2023
Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of ves2023
Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of ves2023
Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of ves2023
Analogs of deutetrabenazine, their preparation and use2021